A new weight loss drug called MariTide caused 20 percent weight loss in a recent trial, even better than Wegovy or Ozempic.

MariTide is being studied for the treatment of obesity and Type 2 diabetes and demonstrated weight loss at 52 weeks.

Canada's health regulator has approved Novo Nordisk's weight-loss drug Wegovy to reduce the risk of nonfatal heart attack or ...

Amgen's experimental weight loss injection, MariTide, showed up to 20% weight loss in patients without diabetes and 17% in ...

North Carolina stopped covering weight loss drugs such as Ozempic for state employees without diabetes. But it extended ...

Regarding Robert F. Kennedy Jr., there is little middle ground — people either love him or hate him. Which is why, after President-elect Donald Trump nominated him to head the Department of Health ...

An increased risk of cardiovascular disease may be present as early as 30 years before a type 2 diabetes diagnosis is made, ...

Kait Handler's debilitating battle with food started as a child. So when she noticed her daughter developing the same diet ...

Health Canada has approved Novo Nordisk’s semaglutide injection, Wegovy, marking it as the first treatment in the country ...

If they commit to supporting long-proven safe vaccinations while increasing transparency and freedom to make choices on newer ...

A class of drugs known as GLP-1s have been helping people lose weight, but out of pocket costs put them out of reach for many Americans. In West Virginia, a subsidy program for public employees was ...

Drugs used for weight loss like Wegovy and Zepbound could be covered by Medicare or Medicaid under a new proposal from the Biden administration.